Molecular Mechanisms of Meiotic Maturation in Drosophila

果蝇减数分裂成熟的分子机制

基本信息

  • 批准号:
    8288746
  • 负责人:
  • 金额:
    $ 32.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-05-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Meiosis is a fundamental process that is coupled to gamete development. Oocytes arrest in prophase of the first meiotic division to allow for growth. Release from prophase I occurs during meiotic maturation, but the molecular mechanisms regulating this process are incompletely understood. Meiotic maturation defects can result in infertility or in inaccurate segregation of chromosomes, leading to miscarriages and/or birth defects. The fruitfly Drosophila melanogaster offers sophisticated genetic and molecular tools, and a well described ovarian cell biology, making it a powerful system to investigate the control of meiotic maturation. Drosophila oocytes enter meiosis shortly after germline cyst formation and arrest in prophase I during most of their development. After meiotic maturation, oocytes arrest again in metaphase I until ovulation. In the prior funding period, we demonstrated that 1-Endosulfine (Endos) is required for meiotic maturation. Our data suggest that Endos promotes the stability of the cell cycle regulators CyclinA, Polo and Twine/Cdc25 (all known to be targets of the Anaphase Promoting Complex, or APC), and that it also has a separate role via inhibition of the E3 ubiquitin ligase Elgi to promote meiotic maturation. Expression of ENSA, the human 1- endosulfine, rescues the endos meiotic defect, and 1-endosulfine is expressed in mouse oocytes, suggesting conservation of the meiotic function of 1-endosulfine. Our overarching hypothesis is that Endos is a central regulator of meiotic maturation via two mechanisms: it inhibits the activity of the APC to allow the accumulation of key cell cycle regulators, and it antagonizes the ubiquitination of Elgi targets. We will test this hypothesis through the following specific aims: 1) to determine if Endos is a negative regulator of the APC; 2) to determine how the E3 ubiquitin ligase Elgi regulates meiotic maturation downstream of Endos; and 3) to elucidate the molecular mechanism of action of Endos. Elucidation of the molecular mechanisms of meiotic maturation could potentially lead to therapies to address this cause of infertility, as well as to new contraceptives. Furthermore, this knowledge could also lead to technological strategies for in vitro maturation of human oocytes to complement current in vitro fertilization methodology. PUBLIC HEALTH RELEVANCE: Failure of the oocyte to undergo meiotic maturation leads to infertility. Our prior work has identified Endos as a major regulator of meiotic maturation, and we propose to use powerful research tools in fruitflies to understand the function of this protein. Our studies could potentially lead to additional therapies to address infertility, as well as to technological strategies to complement current in vitro fertilization methodology.
描述(由申请人提供):减数分裂是一个与配子发育相结合的基本过程。卵母细胞在第一次减数分裂的前期停止生长。前期I的释放发生在减数分裂成熟过程中,但调控这一过程的分子机制尚不完全清楚。减数分裂成熟缺陷可导致不孕症或染色体不准确分离,导致流产和/或出生缺陷。果蝇黑腹果蝇提供了复杂的遗传和分子工具,以及描述良好的卵巢细胞生物学,使其成为研究减数分裂成熟控制的强大系统。果蝇卵母细胞在种系囊肿形成后不久进入减数分裂,在大部分发育过程中停留在I前期。在减数分裂成熟后,卵母细胞在中期再次停滞直到排卵。在之前的资助期内,我们证明了1-亚砜(Endos)是减数分裂成熟所必需的。我们的数据表明,Endos促进细胞周期调节因子CyclinA、Polo和Twine/Cdc25的稳定性(都是后期促进复合体(APC)的靶点),并且它还通过抑制E3泛素连接酶Elgi来促进减数分裂成熟。人1-亚砜(ENSA)的表达可以修复内切细胞减数分裂缺陷,1-亚砜在小鼠卵母细胞中也有表达,表明1-亚砜的减数分裂功能得到了保留。我们的总体假设是,Endos通过两种机制是减数分裂成熟的中心调节剂:它抑制APC的活性以允许关键细胞周期调节剂的积累,并且它对抗Elgi靶点的泛素化。我们将通过以下具体目标来检验这一假设:1)确定Endos是否是APC的负调节因子;2)确定E3泛素连接酶Elgi如何调控endo下游的减数分裂成熟;3)阐明Endos的分子作用机制。减数分裂成熟的分子机制的阐明可能会导致治疗,以解决这一原因的不孕症,以及新的避孕药。此外,这一知识也可能导致人类卵母细胞体外成熟的技术策略,以补充目前的体外受精方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniela Drummond-Barbosa其他文献

Daniela Drummond-Barbosa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniela Drummond-Barbosa', 18)}}的其他基金

Nutrient fuel preference, obesity, and stem cell lineage physiology
营养燃料偏好、肥胖和干细胞谱系生理学
  • 批准号:
    10635071
  • 财政年份:
    2021
  • 资助金额:
    $ 32.47万
  • 项目类别:
Nutrient fuel preference, obesity, and stem cell lineage physiology
营养燃料偏好、肥胖和干细胞谱系生理学
  • 批准号:
    10665801
  • 财政年份:
    2021
  • 资助金额:
    $ 32.47万
  • 项目类别:
Nutrient fuel preference, obesity, and stem cell lineage physiology
营养燃料偏好、肥胖和干细胞谱系生理学
  • 批准号:
    10165881
  • 财政年份:
    2021
  • 资助金额:
    $ 32.47万
  • 项目类别:
Adipocyte metabolism and stem cell lineage responses
脂肪细胞代谢和干细胞谱系反应
  • 批准号:
    10004144
  • 财政年份:
    2017
  • 资助金额:
    $ 32.47万
  • 项目类别:
Molecular Mechanisms of Meiotic Maturation in Drosophila
果蝇减数分裂成熟的分子机制
  • 批准号:
    7887289
  • 财政年份:
    2005
  • 资助金额:
    $ 32.47万
  • 项目类别:
alpha-Endosulfine, Insulin,& Adult Tissue Growth Control
α-硫磺、胰岛素、
  • 批准号:
    7065358
  • 财政年份:
    2005
  • 资助金额:
    $ 32.47万
  • 项目类别:
Nutrient Sensing in Adipocytes and the Control of Oogenesis in Drosophila
脂肪细胞的营养感应和果蝇卵子发生的控制
  • 批准号:
    8758798
  • 财政年份:
    2005
  • 资助金额:
    $ 32.47万
  • 项目类别:
alpha-Endosulfine, Insulin,& Adult Tissue Growth Control
α-硫磺、胰岛素、
  • 批准号:
    7035768
  • 财政年份:
    2005
  • 资助金额:
    $ 32.47万
  • 项目类别:
Nutrient Sensing in Adipocytes and the Control of Oogenesis in Drosophila
脂肪细胞的营养感应和果蝇卵子发生的控制
  • 批准号:
    8908016
  • 财政年份:
    2005
  • 资助金额:
    $ 32.47万
  • 项目类别:
alpha-Endosulfine, Insulin,& Adult Tissue Growth Control
α-硫磺、胰岛素、
  • 批准号:
    7614326
  • 财政年份:
    2005
  • 资助金额:
    $ 32.47万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.47万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了